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Asthma is a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions among
many genes and between these genes and the environment. Numerous loci and candidate genes have been reported
to show linkage and association to asthma and atopy. Although some studies reporting these observations are
compelling, no gene has been mapped that confers a sufficiently high risk of asthma to meet the stringent criteria
for genomewide significance. Using 175 extended Icelandic families that included 596 patients with asthma, we
performed a genomewide scan with 976 microsatellite markers. The families were identified by cross-matching a
list of patients with asthma from the Department of Allergy/Pulmonary Medicine of the National University Hospital
of Iceland with a genealogy database of the entire Icelandic nation. We detected linkage of asthma to chromosome
14q24, with an allele-sharing LOD score of 2.66. After we increased the marker density within the locus to an
average of one microsatellite every 0.2 cM, the LOD score rose to 4.00. We designate this locus “asthma locus
one” (AS1). Taken together, these results provide evidence of a novel susceptibility gene for asthma on chromosome
14q24.
Introduction
Bronchial asthma [MIM 600807], the most common
chronic disease affecting children and young adults, is
a complex genetic disorder with several overlapping phe-
notypes (Cookson and Moffatt 2000; Weiss 2001).
There is strong evidence of a genetic component in
asthma (Bleecker et al. 1997; Kauffmann et al. 2002).
Multiple environmental factors are also known to mod-
ulate the clinical expression of asthma as well as the
asthma-associated phenotypes: bronchial hyperrespon-
siveness, atopy, and elevated immunoglobulin E (IgE)
(Cookson 1999; Holloway et al. 1999; Koppelman and
Postma 1999). It is a commonly held view that asthma
is caused by multiple interacting genes, some having a
protective effect and others contributing to the disease
pathogenesis, with each gene having its own tendency
to be influenced by the environment (Cookson 1999;
Holloway et al. 1999; Koppelman and Postma 1999).
Thus, the complex nature of the asthma phenotype, to-
gether with substantial locus heterogeneity and environ-
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mental influence, has made it difficult to uncover genetic
factors that underlie asthma. Although multiple linkage
and association studies have implicated 1500 atopy and
asthma loci or candidate genes throughout the genome
(Collings et al. 2000), only one linkage study (Lee et al.
2000) has yielded an atopy locus that, without doubt,
meets criteria for genomewide significance (Lander and
Kruglyak 1995), and only a few of the associations re-
ported qualify for possible significance. The regions that
have been most consistently reported to be in linkage or
association with asthma include the cytokine gene clus-
ter on chromosome 5 (including interleukin [IL]-3, IL-
4, IL-5, IL-9, and IL-13), chromosome 11 (the b chain
of FceRI), chromosome 12 (stem cell factor, interferon
g, insulin-like growth factor, and Stat-6), and chromo-
some 16 (IL-4R), suggesting that these regions may har-
bor genes that contribute to the development of asthma
and allergies. In addition, these data support the hy-
pothesis that genes involved in immunological processes
play a critical role in the pathogenesis of asthma. Because
so few of these studies show significance or map genes
with strong, or even moderate, effect, it has been difficult
to interpret many of these results (Green et al. 1998;
Wjst and Immervoll 1998; Unoki et al. 2000; Hakon-
arson et al. 2001; Hakonarson and Wjst 2001). In the
present study, we report significant linkage to chromo-
some 14q24, with a LOD score of 4.00 (Pp 8.70#
), in a genomewide linkage study of 596 patients610
with asthma who are members of 175 Icelandic families.
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Material and Methods
Patients
The original patient list contained the names of
17,000 patients who attended the private clinics or out-
patient clinics of allergists practicing at the Allergy/Pul-
monary Departments of the National University Hos-
pital of Iceland during the years 1977–2001 (European
Community Respiratory Health Survey Group 1997).
For this study, we selected patients with physician-di-
agnosed asthma who were being treated with asthma
drugs and who were related to at least one other patient
within and including six meiotic events (six meiotic
events separate second cousins), as revealed by a com-
puterized genealogy database. The patients were 12–70
years of age (mean 39.3 years), and 62% were female.
Information was gathered regarding age at diagnosis,
medications, hospital admissions, and family history of
atopy and asthma. The diagnoses of asthma and atopy
were clinically reconfirmed in the study by means of a
new physical examination, measurements of skin test
reactivity to 12 aeroallergens (including birch, grass, Ru-
mex crispus, cat, dog, horse, Cladosporium, Mucor, Al-
ternaria, Dermatophagoides pteronyssinus, D. farinae,
and Lepidoglyphus destructor), total IgE levels, and pul-
monary function tests. Unless a baseline forced expira-
tory volume in 1 s (FEV1) was 70% of predicted value
(based on sex, height, and race), a methacholine (MCh)-
challenge test was performed. The phenotype assess-
ments, PFTs, and MCh tests were performed according
to guidelines of the American Thoracic Society (ATS)
(Cockcroft et al. 1977; Palmquist et al. 1988). Patients
were considered atopic if their skin-prick–test reaction
was positive (i.e., 3 mm or 50% of the histamine-
positive control response). The diagnosis of asthma in
Iceland is based on the diagnostic criteria outlined by
the U.S. National Heart, Lung, and Blood Institute and
the ATS (American Thoracic Society 1995; National In-
stitutes of Health 1997) and includes any of the follow-
ing measures:
1. Patient has recurrent symptoms of cough and wheez-
ing for 12 years and demonstrates clinical response
to bronchodilator therapy (as measured by 115%
increase in FEV1 after bronchodilator treatment).
2. Patient has reduced FEV1 (i.e., !80%) at baseline
prior to bronchodilator therapy and shows 115%
improvement in FEV1 after bronchodilator therapy.
3. Patient has recurrent symptoms of coughing and
wheezing, and an MCh test, performed in accor-
dance to ATS guidelines (American Thoracic Society
1995), shows 120% decrease in FEV1 at an MCh
concentration 8 mg/liter.
Severity of asthma was determined by a combination
of signs and symptoms, including PFTs, MCh values,
and requirements for therapy. On the basis of these cri-
teria, ∼90% of the patients were scored as having mild-
to-moderate asthma, and 10% were scored as having
severe asthma. FEV1 180% predicted was considered
normal. Before blood samples were obtained, all patients
included in the study were reexamined by the same two
allergists who had confirmed the asthma phenotype and
severity level and had supervised the measurements of
total IgE levels, spirometry, and skin testing. In the pre-
sent study, a reduction in FEV1 of 20% at an MCh
concentration of 8 mg/liter is considered to be a pos-
itive result.
The patient participation rate for the study exceeded
90%. All patients gave signed informed consent, do-
nated blood samples, completed a detailed medical ques-
tionnaire, and underwent all tests necessary for proper
phenotyping. The study was approved by the Icelandic
Data Protection Commission and the National Bioethics
Committee. Personal identities of the patients and their
family members were subsequently encrypted by the
Data Protection Commission of Iceland (Gulcher et al.
2000). All blood and DNA samples were also coded in
the same way. All participants were asked, by question-
naire, whether they had been diagnosed with asthma
and/or atopy and whether they were receiving drugs to
treat their condition. The names of the drugs were re-
corded and confirmed to be antiasthma and/or antial-
lergy medications. Blood was also collected from close
relatives of the index patients, to increase the informa-
tion available for the linkage analysis. The lung function
of all participants was measured at the time the blood
was drawn for the study.
Pedigrees
deCODE has built a computerized genealogy database
with 1650,000 names that includes all 285,000 living
Icelanders and most of their ancestors (Gulcher and Ste-
fansson 1998). The database has a connectivity 195%
in the 20th century and 186% in the 19th century. Its
maternal connections are 99.3% accurate, as measured
by mitochondrial polymorphisms of maternally linked
individuals (Helgason et al. 2000). The genealogy data-
base was used to cluster the patients in pedigrees. The
genealogy database is reversibly encrypted by the Data
Protection Commission of Iceland before it is used in
our laboratory (Gulcher and Stefansson 1998). Recur-
sive algorithms are used with the encrypted personal
identifiers to find all ancestors in the database who are
related to any member of the patient list within a given
number of preceding generations. The cluster function
then identifies ancestors who are common to any two
or more members of the patient list.
Genotyping
We genotyped 596 patients with asthma who be-
longed to 175 families, in which each patient was related
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to at least one other patient within and including six
meiotic events. DNA samples from all 596 patients and
538 relatives were successfully genotyped, using 976 spe-
cific fluorescently labeled primers, with an initial ge-
nomewide average spacing of 3–4 cM. We have devel-
oped a microsatellite screening set, based, in part, on
the ABI Linkage Marker (v. 2) screening and interca-
lating sets, in combination with 1500 custom-made
markers. All markers were extensively tested for mul-
tiplex PCR results. The PCR amplifications were set up
and pooled using Cyberlab robots. The reaction volume
was 5 ml, and, for each PCR, 20 ng of genomic DNA
was amplified in the presence of 2 pmol of each primer,
0.25 U AmpliTaq Gold, 0.2 mmol/liter dNTPs, and 2.5
mmol/liter MgCl2. The PCR conditions were 95C for
10 minutes, then 37 cycles of 15 s at 94C, 30 s at 55C,
and 1 min at 72C. The PCR products were supple-
mented with the internal size standard, and the pools
were separated and detected on an Applied Biosystems
model 3700 sequencer, using Genescan (v. 3.0) peak-
calling software. Alleles were called automatically with
the DAC program (Fjalldal et al. 2001), and the program
DecodeGT was used to fractionate according to quality
and to edit the called genotypes (Palsson et al. 1999).
In regions that demonstrated linkage by use of the frame-
work marker set, marker density was further increased
(i.e., fine mapping of locus) by additional microsatellite
markers, to obtain an average coverage of 0.2 cM in
these regions.
Statistical Analyses
A genomewide linkage scan was performed using a
framework map of 976 microsatellite markers. We
analyzed the data by use of the Allegro program (Gud-
bjartsson et al. 2000) and determined statistical sig-
nificance by applying affecteds-only allele-sharing
methods (not specifying any particular inheritance
model). The Allegro program, a linkage program de-
veloped at deCODE Genetics, calculates LOD scores on
the basis of multipoint calculations (Kruglyak et al.
1996; Kong and Cox 1997; Gudbjartsson et al. 2000)
and is available at no cost for noncommercial use by
sending e-mail to allegro@decode.is. Our standard link-
age analysis approach uses the Spairs scoring function
(Whittemore and Halpern 1994; Kruglyak et al. 1996),
the exponential allele-sharing model (Kong and Cox
1997), and a family weighting scheme that is halfway,
on the log scale, between weighting each affected pair
equally and weighting each family equally. All genotyped
individuals who are unaffected are treated as “un-
known.” P values are calculated on the basis of the large-
sample theory; Zlr p [2 loge (10) LOD] is approxi-
mately distributed as a standard normal distribution
under the null hypothesis of no linkage (Kong and Cox
1997), and the observed LOD score is compared with
its complete data sampling distribution under the null
hypothesis (Gudbjartsson et al. 2000). The information
measure we use is part of the Allegro program output
(Nicolae 1999) and is closely related to a classical mea-
sure (Dempster et al. 1977). The information value
equals zero if the marker genotypes are completely un-
informative and equals one if the genotypes determine
the exact amount of allele sharing by descent among the
affected relatives. The marker order and positions for
the framework mapping set were obtained using a high-
density genetic map developed at DeCODE (Kong et al.
2002). Data from 146 Icelandic nuclear families (sib-
ships with genotypes for two to seven siblings and for
both parents), providing 1,257 meioses, were analyzed
to estimate the genetic distances. By comparison, dis-
tances in the Marshfield genetic map were estimated on
the basis of 188 meioses. Intermarker distances in the
peak region, after enrichment with four markers, were
estimated using an adaptation of the expectation-max-
imization algorithm (Dempster 1977) within Allegro.
Results
We cross-matched a list of 17,000 patients from the
National University Hospital of Iceland with the gene-
alogy database. In the present study, we included pa-
tients with physician-diagnosed asthma who were re-
lated by six or fewer meiotic events to other patients
with asthma. There were 596 patients in 175 families
with asthma. In the present study 130 families had at
least 6 affected members each. Two of these families are
displayed in figure 1. The patients’ demographic data,
geometric mean IgE values, and results of lung function
tests (including percent predicted FEV1, and FEV1:FVC
ratio), MCh-challenge test, and skin tests for the most
common aeroallergens in Iceland are shown in table 1.
Seventy-three percent of the patients were atopic, as de-
fined by a positive skin-test reaction.
More than 400 of the patients were tested for airway
reactivity by use of MCh challenge. As shown in table
1, although 67% of the patients tested had a 20%
decrease in FEV1 at an MCh concentration of 2 mg/
liter, 190% of the patients tested positive at an MCh
concentration of 8 mg/liter. This would be consistent
with moderate-to-severe airway hyperresponsiveness in
two thirds of our study population. The spirometric val-
ues reported in table 1 are those obtained during the
study, at which time the majority of the patients had
stable asthma and were receiving full therapy; however,
the medical charts of all these patients show previous
spirometric values with FEV1 !80% predicted, at one or
more earlier time points (data not shown). Bronchodi-
lator reversibility was tested in selected patients, includ-
ing those who had negative results of an MCh challenge
and patients for whom the clinician determined the test
to be necessary to support the asthma phenotype.
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Table 1
Demographic Data, Atopic Status, and Lung
Function Values for the Study Population
Variable Valuea
Mean age 39.3 years
Sex (M/F) 38/62
Smoking history (in pack-years):
11 33
110 17
120 and 155 years of age .5
Atopy:
Positive skin test 73
Allergic to:
Animals 43
Pollen 40
Dust mites 12
Mold 4
IgE 137  242b
Lung function:
FEV1 98.4  17.3
b
FEV1/FVC 82.2  9.5
b
MCh challenge:c
8 mg/ml 90
2 mg/ml 67
Asthma severity:
Mild to moderate 90
Severe 10
a Data are percentages, except as otherwise
noted.
b Mean  SD.
c Patients are grouped according to amounts of
MCh required to produce a 20% decrease in FEV1.
Figure 1 Examples of asthma pedigrees used in the linkage analysis. Unaffected siblings of patients are not shown, and sex indicators
have been shuffled for some individuals in the top two generations, to protect privacy. The darkened squares and circles represent affected men
and women, respectively. The slashed symbols represent deceased individuals.
Thirty-three percent of the patients gave a history of
having smoked for 11 pack-year. Of those, 47% had
smoked for !10 pack-years. We cannot exclude the pos-
sibility that some of the study participants who are
smokers had mild coexisting chronic obstructive pul-
monary disease (COPD); however, only 0.5% of the
study patients who were55 years had smoked for20
pack-years (table 1). In contrast, all of our study subjects
have asthma—as defined by the ATS criteria (American
Thoracic Society 1995), which is the phenotype used
for this study—thereby minimizing the potential of con-
founding effects from COPD.
Five hundred ninety-six patients and 538 of their un-
affected (i.e., nonasthmatic) relatives were genotyped
using 976 microsatellite markers in a genomewide link-
age scan. The disease status of relatives was obtained
by use of a questionnaire. We analyzed the data and
determined statistical significance by applying affecteds-
only, allele-sharing methods (which do not specify any
particular inheritance model) (Gulcher et al. 2001).
Since our linkage scan is performed on affected status
only, there is no possible confounding effect from the
relatives, even if we failed to identify an affected relative
in the group. Figure 2 shows the LOD score–tracing
genome scan using the framework markers. The ge-
nomic region that showed the most evidence of linkage
to the asthma phenotype was chromosome 14q24, with
a LOD score of 2.66 (single test ).4Pp 2.16# 10
Given that the information content on identity-by-de-
scent sharing in the region was !85% (i.e., 0.77), which
is less than we prefer, we added another 34 microsat-
ellite markers under this peak to ensure that the results
are a true reflection of the information contained in the
material. This increased the information content at the
peak to 195% and produced a LOD score of 4.00 (single
test ) (fig. 3). This locus is significant6Pp 8.70# 10
on a genomewide basis, even allowing for the multiple-
marker testing, and it corresponds to a genomewide
adjusted P value of !.05 (Lander and Kruglyak 1995).
We designate this locus as “asthma locus one” (AS1).
The locus peak is centered on markers D14S588 and
D14S603, which are spaced 84 kb apart. The locus,
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Figure 2 Genealogy-based genomewide linkage scan of all 596 affected family members, using 976 microsatellite markers. The multipoint
LOD score is shown on the vertical axis, and the distance (in cM) from the p terminus of the chromosome is on the horizontal axis.
defined by a decrease of ∼1.0 in the LOD score, is be-
tween markers D14S1069 and D14S289, centromeric
and telomeric, respectively. The segment with a 1-LOD
decrease is ∼3.9 cM, and we estimate that it corresponds
to ∼3.0 million bases.
Discussion
Our genomewide scan revealed significant linkage of
asthma to chromosome 14q24, indicating that this re-
gion harbors a gene that contributes to the development
of asthma. We included individuals who had a physician-
confirmed diagnosis of asthma and who were taking
asthma medications. The majority of the patients with
asthma were monitored on a regular basis in private
clinics by three allergists/pulmonologists. Accurate in-
formation about medication history and current use of
asthma medication was recorded for all participants.
The extensive computerized genealogy database on Ice-
landers enabled us to identify extended families of pa-
tients with asthma, wherein the initial genomewide link-
age scan (using microsatellite markers with the average
genomewide density of 3–4 cM) demonstrated signifi-
cant linkage to chromosome 14q24 (fig. 2). Several ge-
nomewide linkage scans in asthma and atopy have been
published; however, most of them have not reported re-
sults that meet criteria for significance at a genomewide
level (reviewed by Wjst and Immervoll [1998], Hakonar-
son and Wjst [2001], and Hakonarson et al. [2001]). A
notable exception is the European linkage study of 199
families with atopic dermatitis, which demonstrated sig-
nificant linkage to chromosome 3q21 (Lee et al. 2000).
Three other studies have reported linkage results of ge-
nomewide significance (Lander and Kruglyak 1995) to
the following asthma-associated phenotypes: bronchial
hyperresponsiveness (Xu et al. 2001a), elevated IgE (Xu
et al. 2001b), and mite-sensitive asthma (Yokoucki et al.
2000). A recent study of asthma in the Kainuu popu-
lation of Finland showed linkage on 7q14-15 to high
levels of IgE (nonparametric linkage score 3.9, Pp
); however, the P value did not reach the threshold.0001
for genomewide significance (Laitinen et al. 2001).
Genomewide searches for genes that contribute to
asthma and asthma-associated phenotypes (atopy, high
IgE levels, and bronchial hyperresponsiveness) have
been completed by several investigators, each studying
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Figure 3 Multipoint allele-sharing LOD score of chromosome 14. A framework genome scan is indicated by a dotted line. A fine-mapping
LOD score of 4.00 was detected within the peak region after 34 microsatellite markers were added to obtain a marker density of 0.2 cM,
using deCODE’s high-density genetic map to determine genetic distances. The multipoint LOD score is shown on the vertical axis, and distance
(in cM) from the p terminus of the chromosome is shown on the horizontal axis.
independent sets of families (Marsh et al. 1994; Daniels
et al. 1996; The Collaborative Study of the Genetics of
Asthma 1997; Hizawa et al. 1998; Ober et al. 1998;
Dizier et al. 2000; Wjst et al. 1999; Collings et al. 2000;
Cho et al. 2001). However, it is noteworthy that, apart
from the locus reported by Lee et al. (2000), in their
study of 199 families with atopic dermatitis (eczema),
none of the linkages reported reach the level of ge-
nomewide statistical significance. The first genomewide
scan for linkage to quantitative traits underlying asthma
identified evidence of linkage on chromosomes 4q, 6p
(near the locus for the major histocompatibility com-
plex), 7, 11q (containing FceRI-b), 13q, and 16 (Daniels
1996). A replication sample of families in the same study
demonstrated suggestive linkage to chromosomes 4, 11,
13, and 16 (Daniels 1996). A genome scan for respon-
siveness to house-dust–mite allergen found suggestive
linkage to chromosomes 2q, 6p (near the MHC), 13q,
and 8p (Hizawa et al. 1998). A genome scan in Amer-
ican families from three racial groups revealed weak
linkage to broad regions on chromosomes 2q, 5q, 6p,
12q, and 13q that may constitute replications of the
results of some previous studies (The Collaborative
Study of the Genetics of Asthma 1997) and to 14q. A
two-stage scan in Hutterite families from the United
States found suggestive evidence of linkage and repli-
cation for loci on chromosomes 5q, 12q, 19q, and 21q
(Ober et al. 1998). A screen in German families iden-
tified suggestive linkage to asthma on chromosomes 2q
(near the IL-1 family cluster), 6p, 9, and 12q (The Col-
laborative Study of the Genetics of Asthma 1997). A
two-stage genome scan in French families found repli-
cated linkage on chromosomes 1p, 12q, and 17q (Dizier
et al. 1999). A recent genomic screen for QTL that
underly asthma in 533 Chinese families encompassing
2,551 individuals reported significant linkage of airway
hyperresponsiveness to the D2S1780 marker on chro-
mosome 2 (Xu et al. 2001a). A study of 47 Japanese
families with mite-sensitive atopic asthma reported sig-
nificant linkage to the IL-12B gene locus on 5q31 (Yok-
ouchi et al. 2000). Genome screens in a Dutch popu-
lation (Xu et al. 2001b) showed genomewide significant
results, when IgE was used as a QTL. Thus, the loci
most consistently identified by these screens are on chro-
mosomes 5, 6, 11, 12, and 13.
Given that asthma genes have been difficult to map,
various attempts have been made to perform meta-anal-
ysis, combining the evidence from several studies on
multiple markers in a particular candidate region, and
to summarize the multipoint LOD values evaluated at
the location of each marker. However, this is not always
practical, because of the variability in methods and
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models among different studies. Lonjou et al. (1999)
presented a meta-analysis of a retrospective collabora-
tion for positional cloning of asthma susceptibility by
the Consortium on Asthma Genetics. Combination of
evidence over multiple samples with 1,037 families sup-
ported loci contributing to asthma susceptibility in the
cytokine region on 5q, with a maximum LOD score of
2.61 near the locus of IL-4, but no evidence of linkage
to atopy. Comparable results were obtained from the
analysis of linkage data from five independent studies,
including 3,175 subjects in 569 families from five coun-
tries, who were sampled for the 5q31-33 region (Palmer
et al. 2001). Our genome scan shows, for the first time,
significant linkage of asthma to markers on chromo-
some 14q24. It should be noted that suggestive linkage
to this locus has been reported elsewhere, by investi-
gators in the United Kingdom (Mansur 1999) and the
United States (The Collaborative Study of the Genetics
of Asthma 1997). Chromosome 14q24 contains many
genes that could contribute to the susceptibility to
asthma, including genes that encode for the epidermal
growth factor–response factor 1, phosphatidylinositol
glycan class H, secreted modular calcium-binding pro-
tein 1, a disintegrin, metalloproteinase domain–20 and
–21, and RNA polymerase II transcriptional regulation
mediator, to name a few. However, given that the size
of the region marked by a decrease of 1 in LOD score
is currently ∼3.9 cM, further fine mapping by use of
marker spacing of 0.03–0.05 cM is needed and is under
way. This approach allows for single-point and hap-
lotype-association analysis and is aimed at narrowing
the region of 1-LOD decrease to the most likely can-
didate. We conclude that we have mapped a high-risk
asthma gene on chromosome 14q24.
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